Cue Biopharma, Inc. ( CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases April 7, 2026 10:00 AM EDT Lucinda Warren - Interim CEO, Interim President,Principal ...
Morning Overview on MSN
New molecules curb inflammation while preserving key immune defenses
Researchers at Brigham and Women’s Hospital have identified a new class of small molecules that selectively shut down ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Kit Dillon Kit Dillon is a writer focused on bags and travel gear. He has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results